OtherPublishAheadOfPrint
PET/CT with 18F-FLT: Does It Improve the Therapeutic Management of Metastatic Germ Cell Tumors?
Christina Pfannenberg, Philip Aschoff, Helmut Dittmann, Frank Mayer, Gerald Reischl, Claus von Weyhern, Lothar Kanz, Claus D. Claussen, Roland Bares and Joerg T. Hartmann
Journal of Nuclear Medicine May 2010, DOI: https://doi.org/10.2967/jnumed.109.070425
Christina Pfannenberg
Philip Aschoff
Helmut Dittmann
Frank Mayer
Gerald Reischl
Claus von Weyhern
Lothar Kanz
Claus D. Claussen
Roland Bares
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 1
January 1, 2025
PET/CT with 18F-FLT: Does It Improve the Therapeutic Management of Metastatic Germ Cell Tumors?
Christina Pfannenberg, Philip Aschoff, Helmut Dittmann, Frank Mayer, Gerald Reischl, Claus von Weyhern, Lothar Kanz, Claus D. Claussen, Roland Bares, Joerg T. Hartmann
Journal of Nuclear Medicine May 2010, DOI: 10.2967/jnumed.109.070425
PET/CT with 18F-FLT: Does It Improve the Therapeutic Management of Metastatic Germ Cell Tumors?
Christina Pfannenberg, Philip Aschoff, Helmut Dittmann, Frank Mayer, Gerald Reischl, Claus von Weyhern, Lothar Kanz, Claus D. Claussen, Roland Bares, Joerg T. Hartmann
Journal of Nuclear Medicine May 2010, DOI: 10.2967/jnumed.109.070425
Jump to section
Related Articles
Cited By...
- Reporter nanoparticle that monitors its anticancer efficacy in real time
- PET Imaging of Proliferation with Pyrimidines
- Postchemotherapy Residual Masses in Nonseminomatous Germ Cell Tumor Patients: 18F-FLT PET Is Unlikely to Identify Mature Teratoma, but Imaging of {alpha}v{beta}3 Integrin Expression Could
- Can Evaluation of Targeted Therapy in Oncology Be Improved by Means of 18F-FLT?
- Monitoring Tumor Response to Therapy with 18F-FLT PET